Ivermectine Biogaran

Ivermectin, the active ingredient in Ivermectine Biogaran, is an anthelmintic presented as an oral formulation for oral use. It treats a range of parasitic infections in humans, including strongyloidiasis, onchocerciasis, scabies, lymphatic filariasis and cutaneous larva migrans, and is administered under medical supervision.

GNH USA supplies Ivermectine Biogaran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory‑compliant shipments to global markets.

Ivermectine Biogaran (ivermectin) is used to treat parasitic diseases that affect the skin, lymphatic system and intestinal tract. - Strongyloidiasis: eradicates intestinal Strongyloides stercoralis infection, reducing gastrointestinal symptoms. - Onchocerciasis: eliminates Onchocerca volvulus microfilariae, helping control river blindness. - Scabies: kills Sarcoptes scabiei mites, relieving itching and skin lesions. - Lymphatic filariasis: reduces Wuchereria bancrofti adult worms, aiding in disease control. - Cutaneous larva migrans: destroys migrating hookworm larvae in the skin, accelerating lesion resolution.

Ivermectine Biogaran may cause adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Nausea: mild stomach upset. - Diarrhea: loose stools. - Dizziness: transient light‑headedness. - Pruritus: itching at the site of infection. - Headache: mild to moderate. - Fatigue: general tiredness.

Serious or Rare Side Effects: - Encephalopathy: altered mental status or seizures. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatotoxicity: elevated liver enzymes or jaundice. - Hypotension: sudden drop in blood pressure. - Anaphylaxis: acute allergic reaction with respiratory distress.

Before prescribing Ivermectine Biogaran, clinicians should consider several safety measures. - Assess liver function: evaluate hepatic status as ivermectin is metabolized hepatically. - Review allergy history: avoid in patients with known hypersensitivity to ivermectin or excipients. - Monitor neurologic signs: watch for dizziness, ataxia or visual disturbances. - Use caution in high parasite load: large infestations may increase risk of severe reactions. - Consider pregnancy status: weigh benefits against potential risks when prescribing to pregnant women. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Ivermectine Biogaran can interact with other medicines, affecting its safety or efficacy.

Major Interactions (Avoid): - P‑glycoprotein inhibitors (e.g., cyclosporine, verapamil): may raise ivermectin plasma concentrations. - CNS depressants (e.g., benzodiazepines, alcohol): increase risk of neurotoxicity.

Moderate Interactions (Monitor Closely): - Warfarin: may potentiate anticoagulant effect, requiring INR monitoring. - Antiretrovirals (e.g., ritonavir): can alter ivermectin metabolism. - Macrolide antibiotics (e.g., erythromycin): may affect drug levels. - Antifungals (e.g., ketoconazole): potential for increased exposure.